Cubist Systematic Strategies, LLC Applied Genetic Technologies Corp Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.87 - $2.91 $22,871 - $35,592	-12,231 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.01 - $4.12 $1,047 - $1,433	348 Added 2.93%	12,231 $37,000
Q2 2021 Aug 16, 2021	SELL	$3.62 - $5.23 $15,971 - $23,074	-4,412 Reduced 27.08%	11,883 $46,000
Q1 2021 May 17, 2021	BUY	$3.94 - $8.19 $64,202 - $133,456	16,295 New	16,295 $83,000
Q1 2019 May 15, 2019	SELL	$2.62 - $4.44 $2,921 - $4,950	-1,115 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.28 - $7.15 $2,542 - $7,972	1,115 New	1,115 $3,000
Q3 2018 Nov 14, 2018	SELL	$3.85 - $7.35 $10,433 - $19,918	-2,710 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.65 $10,027 - $15,311	2,710 New	2,710 $10,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.